TuisORCHPHARMA • NSE
add
Orchid Pharma Ltd
Vorige sluiting
₹1 644,00
Dagwisseling
₹1 577,90 - ₹1 664,05
Jaarwisseling
₹702,75 - ₹1 997,40
Markkapitalisasie
81,41 mjd INR
Gemiddelde volume
67,26 k
P/V-verhouding
67,00
Dividend-opbrengs
-
Primêre beurs
NSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 2,23 mjd | 12,05% |
Bedryfskoste | 698,25 m | 14,56% |
Netto inkomste | 272,36 m | 37,53% |
Netto winsgrens | 12,23 | 22,79% |
Wins per aandeel | 5,37 | — |
EBITDA | 302,47 m | 30,11% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 2,44 mjd | 384,25% |
Totale bates | 16,35 mjd | 9,59% |
Totale aanspreeklikheid | 4,11 mjd | 6,94% |
Totale ekwiteit | 12,24 mjd | — |
Uitstaande aandele | 50,72 m | — |
Prys om te bespreek | 6,81 | — |
Opbrengs op bates | — | — |
Opbrengs op kapitaal | 4,03% | — |
Kontantvloei
Netto kontantverandering
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 272,36 m | 37,53% |
Kontant van bedrywe | — | — |
Kontant van beleggings | — | — |
Kontant van finansiering | — | — |
Netto kontantverandering | — | — |
Beskikbare kontantvloei | — | — |
Meer oor
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Gestig
1992
Webwerf
Werknemers
871
